AMENDMENT TO CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • April 20th, 2023 • China Pharma Holdings, Inc. • Pharmaceutical preparations
This Amendment to Convertible Promissory Note (this “Amendment”) is entered into as of April 13, 2023, by and between Streeterville Capital, LLC, a Utah limited liability company (“Lender”), and China Pharma Holdings, Inc., a Nevada corporation (“Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below).
